SECONDARY GENETIC ABBERATIONS AND THEIR EFFECT ON PROGNOSIS IN CORE BINDING FACTOR - ACUTE MYELOID LEUKEMIA (CBF-AML)

被引：0
|
作者：
Markova, J. [1 ]
Trnkova, Z. [1 ]
Maaloufova, J. [1 ]
Stary, J. [2 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic
[2] Fac Hosp Motol, Dept Pediat Hematol & Oncol, Prague 5, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0501
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] Core binding factor acute myeloid leukemia (CBF-AML) in Mexico: A single institution experience
    Ruiz-Delgado, Guillermo J.
    Macias-Gallardo, Julio
    Lutz-Presno, Julia
    Garces-Eisele, Javier
    Hernandez-Arizpe, Ana
    Montes-Montiel, Maryel
    Ruiz-Argueelles, Guillermo J.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (01): : 25 - 30
  • [2] Mutational Landscape of Relapsed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Dolnik, Anna
    Jahn, Nikolaus
    Strang, Eric
    Cocciardi, Sibylle
    Rucker, Frank G.
    Panina, Ekaterina
    Blatte, Tamara J.
    Herzig, Julia Katharina
    Corbacioglu, Andrea
    Weber, Daniela
    Schrade, Anika
    Gaidzik, Verena I.
    Skambraks, Sabrina
    Gotze, Katharina S.
    Luebbert, Michael
    Fiedler, Walter
    Schroeder, Thomas
    Hahn, Corinna
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    Bullinger, Lars
    BLOOD, 2020, 136
  • [3] Clonal architecture of pediatric core binding factor-acute myeloid leukemia (CBF-AML)
    Nasedkina, Tatiana
    Ghukasyan, Lilit
    Krasnov, Georgii
    Baidun, Lyudmila
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 371 - 371
  • [4] Clinical Outcomes of Adults With Core Binding Factor Acute Myeloid Leukemia (CBF-AML): A Single Center Experience
    Chan, Kok Hoe
    Yohannan, Binoy
    Sridhar, Arthi
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S289 - S289
  • [5] THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
    Markova, J.
    Polak, J.
    Haskovec, C.
    Maaloufova, J.
    Markova, M.
    Soukup, P.
    Salek, C.
    Vrana, M.
    Dobrovolna, M.
    Vitek, A.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2013, 98 : 522 - 522
  • [6] Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis
    Deotare, Uday
    Shaheen, Marwan
    Brandwein, Joseph M.
    Pitcher, Bethany
    Kamel-Reid, Suzanne
    Yee, Karen W. L.
    Schimmer, Aaron
    Minden, Mark D.
    Gupta, Vikas
    Schuh, Andre C.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 810 - 813
  • [7] Kit Mutations at Exon-17 Correlate with Adverse Survival in Children with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Srinivasan, S.
    Dhamne, C.
    Moulik, N. Roy
    Shetty, D.
    Tembhare, P.
    Patkar, N.
    Pg, S.
    Narula, G.
    Banavali, S. D.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S91 - S91
  • [8] Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Jahn, Nikolaus
    Bullinger, Lars
    Teleanu, Maria-Veronica
    Gaidzik, Verena I.
    Weber, Daniela
    Goehring, Gudrun
    Luebbert, Michael
    Fiedler, Walter
    Brossart, Peter
    Kindler, Thomas
    Radsak, Markus
    Ringhoffer, Mark
    Goetze, Katharina S.
    Greil, Richard
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlenk, Richard F.
    Doehner, Hartmut
    Paschka, Peter
    Doehner, Konstanze
    BLOOD, 2015, 126 (23)
  • [9] Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?
    Dombret, Herve
    Preudhomme, Claude
    Boissel, Nicolas
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (02) : 92 - 97
  • [10] Prognostic significance of WBC, age, and cytogenetics in patients with core binding factor acute myeloid leukemia (CBF-AML): A comparative study from the French AML Intergroup.
    Delaunay, J
    Leblanc, T
    Blaise, D
    Fenaux, P
    Huguet-Rigal, F
    Witz, F
    Pigneux, A
    Thomas, X
    Auvrignon, A
    Colombat, P
    Lioure, B
    Van den Akker, J
    Mugneret, F
    Bastard, C
    Dastugue, N
    Castaigne, S
    Reiffers, J
    Leverger, G
    Harousseau, JL
    Dombret, H
    BLOOD, 2002, 100 (11) : 748A - 748A
12345